GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sagittarius Life Science Corp (ROCO:3205) » Definitions » Gross-Profit-to-Asset %

Sagittarius Life Science (ROCO:3205) Gross-Profit-to-Asset % : 14.01% (As of Mar. 2025)


View and export this data going back to 2005. Start your Free Trial

What is Sagittarius Life Science Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Sagittarius Life Science's annualized Gross Profit for the quarter that ended in Mar. 2025 was NT$71.4 Mil. Sagittarius Life Science's average Total Assets over the quarter that ended in Mar. 2025 was NT$509.9 Mil. Therefore, Sagittarius Life Science's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 was 14.01%.


Sagittarius Life Science Gross-Profit-to-Asset % Historical Data

The historical data trend for Sagittarius Life Science's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sagittarius Life Science Gross-Profit-to-Asset % Chart

Sagittarius Life Science Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.15 14.20 13.16 11.49 13.70

Sagittarius Life Science Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.08 13.96 12.01 16.84 14.01

Competitive Comparison of Sagittarius Life Science's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Sagittarius Life Science's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sagittarius Life Science's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sagittarius Life Science's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Sagittarius Life Science's Gross-Profit-to-Asset % falls into.


;
;

Sagittarius Life Science Gross-Profit-to-Asset % Calculation

Sagittarius Life Science's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=81.112/( (664.723+519.825)/ 2 )
=81.112/592.274
=13.70 %

Sagittarius Life Science's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=71.42/( (519.825+499.921)/ 2 )
=71.42/509.873
=14.01 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2025) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Sagittarius Life Science Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Sagittarius Life Science's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sagittarius Life Science Business Description

Traded in Other Exchanges
N/A
Address
No. 3, Park Street, 10-6th Floor, Nangang District, Taipei, TWN
Sagittarius Life Science Corp is a Taiwan based company engaged in operating as a biotechnology and pharmaceutical company. Its business activity is to develop Chinese herbal medicines and supplements for the treatment of bone fractures, osteoporosis, wound healing and skin care.

Sagittarius Life Science Headlines

No Headlines